Back to Browse Journals » Vascular Health and Risk Management » Volume 7

Vascular Health and Risk Management


Archive: Volume 7, 2011

Benefits of once-daily therapies in the treatment of hypertension

Flack JM, Nasser SA

Vascular Health and Risk Management 2011, 7:777-787

Published Date: 21 December 2011

The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive

Falskov B, Hermann TS, Rask-Madsen C, Major-Pedersen A, Christiansen B, Raunsø J, Køber L, Torp-Pedersen C, Dominguez H

Vascular Health and Risk Management 2011, 7:771-776

Published Date: 19 December 2011

Differential clinical profile of candesartan compared to other angiotensin receptor blockers

Cernes R, Mashavi M, Zimlichman R

Vascular Health and Risk Management 2011, 7:749-759

Published Date: 12 December 2011

Critical review of cancer risk associated with angiotensin receptor blocker therapy

Wuerzner G, Burnier M, Waeber B

Vascular Health and Risk Management 2011, 7:741-747

Published Date: 12 December 2011

Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension

Palatini P, Casiglia E, Gąsowski J, Głuszek J, Jankowski P, Narkiewicz K, Saladini F, Stolarz-Skrzypek K, Tikhonoff V, Van Bortel L, Wojciechowska W, Kawecka-Jaszcz K

Vascular Health and Risk Management 2011, 7:725-739

Published Date: 7 December 2011

Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium

Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ

Vascular Health and Risk Management 2011, 7:719-724

Published Date: 2 December 2011

Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension

Topouchian J, Agnoletti D, Blacher J, Youssef A, Ibanez I, Khabouth J, Khawaja S, Beaino L, Asmar R

Vascular Health and Risk Management 2011, 7:709-717

Published Date: 30 November 2011

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting

Vogt A, Schoelmerich A, Pollner F, Schlitt M, Raaz U, Maegdefessel L, Reindl I, Buerke M, Werdan K, Schlitt A

Vascular Health and Risk Management 2011, 7:693-699

Published Date: 22 November 2011

Effect of alcohol and tobacco use on vascular dementia: a matched case control study

Takahashi PY, Caldwell CR, Targonski PV

Vascular Health and Risk Management 2011, 7:685-691

Published Date: 15 November 2011

Telmisartan and cardioprotection

Akhrass PR, McFarlane SI

Vascular Health and Risk Management 2011, 7:677-683

Published Date: 15 November 2011

Vitamin D status and peripheral arterial disease: evidence so far

Chua GT, Chan YC, Cheng SW

Vascular Health and Risk Management 2011, 7:671-675

Published Date: 15 November 2011

Hemorrhagic infarction at 33 days after birth in a healthy full-term neonate

Kubo Y, Ogasawara K, Kurose A, Kashimura H, Koji T, Otawara Y, Kamei J, Akasaka M, Sasaki M, Ogawa A

Vascular Health and Risk Management 2011, 7:667-670

Published Date: 8 November 2011

Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level

Bestehorn K, Jannowitz C, Horack M, Karmann B, Halle M, Völler H

Vascular Health and Risk Management 2011, 7:639-647

Published Date: 31 October 2011

Effects of smoking cessation on central blood pressure and arterial stiffness

Takami T, Saito Y

Vascular Health and Risk Management 2011, 7:633-638

Published Date: 20 October 2011

Prevalence of significant carotid artery stenosis in Iranian patients with peripheral arterial disease

Bavil AS, Ghabili K, Daneshmand SE, Nemati M, Bavil MS, Namdar H, Shaafi S

Vascular Health and Risk Management 2011, 7:629-632

Published Date: 11 October 2011

Troponin elevation in conditions other than acute coronary syndromes

Tanindi A, Cemri M

Vascular Health and Risk Management 2011, 7:597-603

Published Date: 22 September 2011

Signs for early diagnosis of heart failure in primary health care

Devroey D, Van Casteren V

Vascular Health and Risk Management 2011, 7:591-596

Published Date: 14 September 2011

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials

Grossman E, Laudon M, Zisapel N

Vascular Health and Risk Management 2011, 7:577-584

Published Date: 15 September 2011

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention

Pham PA, Pham PT, Pham PC, Miller JM, Pham PM, Pham SV

Vascular Health and Risk Management 2011, 7:551-567

Published Date: 26 August 2011

Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production

Brown MD, Feairheller DL, Thakkar S, Veerabhadrappa P, Park JY

Vascular Health and Risk Management 2011, 7:541-550

Published Date: 26 August 2011

Extended-release ranolazine: critical evaluation of its use in stable angina

Truffa AAM, Newby LK, Melloni C

Vascular Health and Risk Management 2011, 7:535-539

Published Date: 25 August 2011

Lipid-lowering therapy: who can benefit

Lewis SJ

Vascular Health and Risk Management 2011, 7:525-534

Published Date: 24 August 2011

Arterial function of carotid and brachial arteries in postmenopausal vegetarians

Su TC, Torng PL, Jeng JS, Chen MF, Liau CS

Vascular Health and Risk Management 2011, 7:517-523

Published Date: 23 August 2011

Renal artery stenosis in kidney transplants: assessment of the risk factors

Etemadi J, Rahbar K, Haghighi AN, Bagheri N, Falaknazi K, Ardalan MR, Ghabili K, Shoja MM

Vascular Health and Risk Management 2011, 7:503-507

Published Date: 10 August 2011

Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study

Radaideh G, Choueiry P, Ismail A, Eid E, Berrou JP, Sedefdjian A, Sévenier F, Pathak A

Vascular Health and Risk Management 2011, 7:491-495

Published Date: 1 August 2011

Incident prediabetes/diabetes and blood pressure in urban and rural communities in the Democratic Republic of Congo

Hightower JD, Hightower CM, Salazar Vázquez BY, Intaglietta M

Vascular Health and Risk Management 2011, 7:483-489

Published Date: 22 July 2011

Pre-eclampsia: pathophysiology, diagnosis, and management

Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M

Vascular Health and Risk Management 2011, 7:467-474

Published Date: 19 July 2011

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview

Hillegass WB, Brott BC, Dobbs JC, Papapietro SE, Misra VK, Zoghbi GJ

Vascular Health and Risk Management 2011, 7:445-459

Published Date: 18 July 2011

Depression in vascular pathologies: the neurologist's point of view

Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G

Vascular Health and Risk Management 2011, 7:433-443

Published Date: 12 July 2011

Racial differences in the responses to shear stress in human umbilical vein endothelial cells

Feairheller DL, Park J-Y, Rizzo V, Kim B, Brown MD

Vascular Health and Risk Management 2011, 7:425-431

Published Date: 11 July 2011

Risk factor investigation for cardiovascular health through WHO STEPS approach in Ardabil, Iran

Sadeghi-Bazargani H, Jafarzadeh H, Fallah M, Hekmat S, Bashiri J, Hosseingolizadeh GH, Soltanmohammadzadeh MS, Mortezazadeh A, Shaker A, Danehzan M, Zohouri A, Khosravi O, Nasimidoust R, Malekpour N, Kharazmi E, Babaei M, Nadirmohammadi M, Mashhadi-Abdoll H

Vascular Health and Risk Management 2011, 7:417-424

Published Date: 11 July 2011

Stiffness of the large arteries in individuals with and without Down syndrome

Rodrigues AN, Coelho LC, Goncalves WLS, Gouvea SA, Vasconcellos MJR, Cunha RS, Abreu GR

Vascular Health and Risk Management 2011, 7:375-381

Published Date: 9 June 2011

Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out

Codreanu I, Robson MD, Rider OJ, Pegg TJ, Jung BA, Dasanu CA, Clarke K, Holloway CJ

Vascular Health and Risk Management 2011, 7:365-373

Published Date: 8 June 2011

Stentless aortic valve replacement: an update

Kobayashi J

Vascular Health and Risk Management 2011, 7:345-351

Published Date: 2 June 2011

Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation

Sezer ED, Sozmen EY, Nart D, Onat T

Vascular Health and Risk Management 2011, 7:333-343

Published Date: 1 June 2011

Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods

Barbosa J, Rodrigues A, Mota C, Barbosa M, Simoes e Silva AC

Vascular Health and Risk Management 2011, 7:287-295

Published Date: 10 May 2011

Cognitive evolution in hypertensive patients: a six-year follow-up

Vicario A, del Sueldo MA, Zilberman JM, Cerezo GH

Vascular Health and Risk Management 2011, 7:281-285

Published Date: 5 May 2011

Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta

Xue Y-L, Shi H-X, Murad F, Bian K

Vascular Health and Risk Management 2011, 7:273-280

Published Date: 28 April 2011

Surgery in current therapy for infective endocarditis

Head SJ, Mokhles MM, Osnabrugge RLJ, Bogers AJJC, Kappetein AP

Vascular Health and Risk Management 2011, 7:255-263

Published Date: 19 April 2011

The causes, consequences, and treatment of left or right heart failure

Pazos-Lopez P, Peteiro-Vazquez J, Garcia-Campos A, Garcia-Bueno L, Abugattas-de-Torres JP, Castro-Beiras A

Vascular Health and Risk Management 2011, 7:237-254

Published Date: 4 April 2011

Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program

Abraham I, MacDonald K, Hermans C, Aerts A, Lee C, Brié H, Vancayzeele S

Vascular Health and Risk Management 2011, 7:209-235

Published Date: 31 March 2011

Doppler study of cerebral arteries in hypercholesterolemia

Farhoudi M, Mehrvar K, Aslanabadi N, Ghabili K, Baghmishe NR, Ilkhchoei F

Vascular Health and Risk Management 2011, 7:203-207

Published Date: 31 March 2011

The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation

Schmidt C, Kisselbach J, Schweizer PA, Katus HA, Thomas D

Vascular Health and Risk Management 2011, 7:193-202

Published Date: 31 March 2011

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders

Mingorance C, Rodríguez-Rodríguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD

Vascular Health and Risk Management 2011, 7:169-176

Published Date: 28 March 2011

Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications

Carlos V Serrano Jr, Karina Tiemi Setani, Erica Sakamoto, et al

Vascular Health and Risk Management 2011, 7:159-164

Published Date: 16 March 2011

Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience

Hikmat N Abdel-Razeq, Asem H Mansour, Yousef M Ismael

Vascular Health and Risk Management 2011, 7:153-158

Published Date: 15 March 2011

Skeletonized coronary arteries: pathophysiological and clinical aspects of vascular calcification

Carlos V Serrano Jr, Marcelo Oranges, Vitor Brunaldi, et al

Vascular Health and Risk Management 2011, 7:143-151

Published Date: 9 March 2011

Treatment options for hypertension in high-risk patients

Wei-Chuan Tsai

Vascular Health and Risk Management 2011, 7:137-141

Published Date: 9 March 2011

Coronary sinus intervention for the treatment of refractory angina pectoris

Yoav Paz, Amihay Shinfeld

Vascular Health and Risk Management 2011, 7:135-136

Published Date: 3 March 2011

Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease

Marco Matteo Ciccone, Asabella Artor Niccoli, Pietro Scicchitano, et al

Vascular Health and Risk Management 2011, 7:129-134

Published Date: 4 March 2011

Novel drug-eluting stents in the treatment of de novo coronary lesions

Davide Capodanno, Fabio Dipasqua, Corrado Tamburino

Vascular Health and Risk Management 2011, 7:103-118

Published Date: 25 February 2011

Endothelial function in a cardiovascular risk population with borderline ankle–brachial index

Kari Syvänen, Päivi Korhonen, Auli Partanen, et al

Vascular Health and Risk Management 2011, 7:97-101

Published Date: 23 February 2011

Decline of arterial cerebral infarction among young women: the Bergen Stroke Study

Halvor Naess, Annette Fromm, Ole Erik Iversen, et al

Vascular Health and Risk Management 2011, 7:81-84

Published Date: 15 February 2011

Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus

Samuel O Olusi, Sunila George

Vascular Health and Risk Management 2011, 7:75-80

Published Date: 15 February 2011

Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study

Ersen B Colkesen, Bart S Ferket, Jan GP Tijssen, et al

Vascular Health and Risk Management 2011, 7:67-74

Published Date: 9 February 2011

Relevance of tumor angiogenesis patterns as a diagnostic value and prognostic indicator in oral precancer and cancer

Devi Charan Shetty, Puneet Ahuja, DK Taneja, et al

Vascular Health and Risk Management 2011, 7:41-47

Published Date: 27 January 2011

Congenital agenesis of internal carotid artery with ipsilateral Horner presenting as focal neurological symptoms

Wassim Farhat, Rechdi Ahdab, Hassan Hosseini

Vascular Health and Risk Management 2011, 7:37-40

Published Date: 26 January 2011

Hyperhomocysteinemia decreases bone blood flow

Neetu Tyagi, Thomas P Vacek, John T Fleming, et al

Vascular Health and Risk Management 2011, 7:31-35

Published Date: 25 January 2011

Antiplatelet combinations for prevention of atherothrombotic events

Mario Bollati, Fiorenzo Gaita, Matteo Anselmino

Vascular Health and Risk Management 2011, 7:23-30

Published Date: 12 January 2011

ACE up the sleeve – are vascular patients medically optimized

AP Coveney, GC O'Brien, GJ Fulton

Vascular Health and Risk Management 2011, 7:15-21

Published Date: 7 January 2011